The pro-inflammatory cytokine tumour necrosis factor alpha (TNFα) plays an important role in the pathogenesis of multiple inflammatory diseases and biological agents that block TNF activity have been successfully used to treat rheumatoid arthritis, Crohn's disease, psoriatic arthritis and ankylosing spondylitis [1]. This evidence concerns the gene TNF and psoriatic arthritis.